Back to User profile » Dr Pengliang Xin
Paper published by Dr Pengliang Xin:
Original Research
Efficacy of the dual PI3K and mTOR inhibitor NVP-BEZ235 in combination with imatinib mesylate against chronic myelogenous leukemia cell lines
Xin P, Li C, Zheng Y, Peng Q, Xiao H, Huang Y, Zhu X
Drug Design, Development and Therapy 2017, 11:1115-1126
Published Date: 3 April 2017